Clinical trial
Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of…
NCT00308126 · Fresenius Kabi, Industry · Completed
Key facts
| NCT number | NCT00308126 |
|---|---|
| Title | Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery |
| Official title | Phase IV, Open-Label, Randomized, Albumin-Controlled, Parallel Group, Multicenter Study to Evaluate the Effect of Medium Molecule HES (130/0.4) in Complications for Patients After Abdominal Surgery |
| Lead sponsor | Fresenius Kabi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postoperative Complications |
| Intervention type | Drug |
| Interventions | Hydroxyethyl Starch 130/0.4 (Voluven) |
| Enrollment | 624 |
| Start date | Jun 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Mar 29, 2006 |
| Last update posted | Dec 11, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: